Precision Biosciences (DTIL) Interest Expenses (2019 - 2026)
Precision Biosciences (DTIL) reported Interest Expenses of $311000.0 for Q1 2026, down 12.15% year-over-year from $354000.0 in Q1 2025, and down 10.63% quarter-over-quarter from $348000.0 in Q4 2025.
Precision Biosciences (DTIL) Interest Expenses (2019 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 7 years of Interest Expenses data on file, last reported at $311000.0 in Q1 2026.
- Interest Expenses for Q1 2026 came in at $311000.0, down 12.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 11.72% YoY), and the FY2025 annual result was $1.4 million, down 20.2% from the prior year.
- Interest Expenses eased to $311000.0 in Q1 2026 per DTIL's latest filing, from $348000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $579000.0 in Q4 2023 and troughed at $42000.0 in Q1 2022.
- A 5-year average of $403294.1 and a median of $392000.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses surged 1142.86% in 2023, then plunged 55.56% in 2024.
- A 5-year view of Interest Expenses shows it stood at $486000.0 in 2022, then climbed by 19.14% to $579000.0 in 2023, then plunged by 32.3% to $392000.0 in 2024, then slipped by 11.22% to $348000.0 in 2025, then dropped by 10.63% to $311000.0 in 2026.
- Business Quant data shows DTIL's Interest Expenses at $311000.0 in Q1 2026, $348000.0 in Q4 2025, and $362000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | 311,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 311,000.00 |
| Mar 31, 2026 | 311,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Sep 30, 2025 | 362,000.00 |
| Sep 30, 2025 | 362,000.00 |
| Jun 30, 2025 | 358,000.00 |
| Jun 30, 2025 | 358,000.00 |
| Mar 31, 2025 | 354,000.00 |
| Mar 31, 2025 | 354,000.00 |
| Dec 31, 2024 | 392,000.00 |
| Dec 31, 2024 | 392,000.00 |
| Sep 30, 2024 | 256,000.00 |
| Sep 30, 2024 | 256,000.00 |
| Jun 30, 2024 | 560,000.00 |
| Jun 30, 2024 | 560,000.00 |
| Mar 31, 2024 | 574,000.00 |
| Mar 31, 2024 | 574,000.00 |
| Dec 31, 2023 | 579,000.00 |
| Dec 31, 2023 | 579,000.00 |